Provolol Pharmaceutical (000739.SZ): Oseltamivir phosphate suspension obtained drug registration certificate

Zhitongcaijing · 2d ago

Zhitong Finance App News, Prologan Pharmaceutical (000739.SZ) issued an announcement. Recently, Zhejiang Pulo Kangyu Pharmaceutical Co., Ltd., a holding subsidiary of the company, received the “Drug Registration Certificate” for oseltamivir phosphate suspension issued by the State Drug Administration.

The active metabolite of oseltamivir phosphate (oseltamivir carboxylate) is a selective influenza virus neuraminidase inhibitor. It can inhibit the neuraminidase activity of influenza A and B viruses, and reduce the spread of influenza A or B viruses by inhibiting the release of the virus from infected cells. Oseltamivir phosphate dry suspension is used for the treatment of influenza A and B in patients aged 2 weeks and above and the prevention of influenza A and B in people aged 1 year and above.